Company: NHICW
Filing Date: 2025-01-02
Form Type: S-1
Source: 0001213900-25-000455
Chunk: 263

Company: NewHold Investment Corp. III
Filing Date: 2025-01-02
Form: S-1
Chunk 263
---
 included in the units offered by this prospectus, and assuming no purchase of units in this offering, by: •each person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; •each of our officers, directors and director nominees; and •all our officers and directors as a group. Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all of our ordinary shares beneficially owned by them. The following table does not reflect record or beneficial ownership of the private warrants as these warrants are not exercisable within 60 days of the date of this prospectus. In September 2024, our sponsor purchased, and the Company issued to the sponsor, 5,031,250 Class B ordinary shares for an aggregate purchase price of $25,000. Subsequently, on October28, 2024, the Company capitalized $167.64 standing to the credit of the Company’s share premium account and issued to the sponsor an additional 1,676,413 Class B ordinary shares, as a result of which the sponsor has purchased and holds an aggregate of 6,707,663 Class B ordinary shares (up to 874,912 of which are subject to forfeiture by the holders thereof depending on the extent to which the underwriter’s over -allotmentoption is exercised). Following and as a result of that capitalization and issuance of additional founder shares, the sponsor is deemed to have purchased the founder shares for $0.004 per share. Prior to the initial investment in the company of $25,000 by the sponsor, the company had no assets, tangible or intangible. The purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 20,125,000 units if the underwriters’ over -allotmentoption is exercised in full, and therefore that such founder shares would represent 25% of the outstanding shares after this offering (not including the Class A ordinary shares that are included within the private units). Up to 874,912 of the founder shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentis exercised. The non -managingsponsor investors have expressed to us an interest in purchasing (i) up to an aggregate of approximately [_]